Specify a stock or a cryptocurrency in the search bar to get a summary
Joinn Laboratories(China)Co
603127Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China. Address: A5 Rongjing East Street, Beijing, China, 100176
Analytics
WallStreet Target Price
98.22 CNYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603127
Dividend Analytics 603127
Dividend growth over 5 years
617 %Continuous growth
5 yearsPayout Ratio 5 years average
24 %Dividend History 603127
Stock Valuation 603127
Financials 603127
Results | 2019 | Dynamics |